科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2020/02/07 | 6,130 | 6,200 | 6,110 | 6,140 | +30 | +0.5% | 151,600 |
| 2020/02/06 | 6,050 | 6,170 | 6,050 | 6,110 | +160 | +2.7% | 155,700 |
| 2020/02/05 | 5,900 | 5,990 | 5,860 | 5,950 | +70 | +1.2% | 98,600 |
| 2020/02/04 | 5,940 | 5,950 | 5,850 | 5,880 | -50 | -0.8% | 108,500 |
| 2020/02/03 | 5,770 | 6,050 | 5,770 | 5,930 | +110 | +1.9% | 269,100 |
| 2020/01/31 | 5,810 | 5,880 | 5,790 | 5,820 | +80 | +1.4% | 91,700 |
| 2020/01/30 | 5,850 | 5,870 | 5,710 | 5,740 | -160 | -2.7% | 74,400 |
| 2020/01/29 | 5,880 | 5,910 | 5,830 | 5,900 | +40 | +0.7% | 73,400 |
| 2020/01/28 | 5,830 | 5,870 | 5,780 | 5,860 | +10 | +0.2% | 97,600 |
| 2020/01/27 | 5,840 | 5,870 | 5,780 | 5,850 | -90 | -1.5% | 112,400 |
| 2020/01/24 | 5,990 | 5,990 | 5,880 | 5,940 | -10 | -0.2% | 68,700 |
| 2020/01/23 | 6,020 | 6,040 | 5,930 | 5,950 | -150 | -2.5% | 78,900 |
| 2020/01/22 | 6,060 | 6,120 | 6,060 | 6,100 | +10 | +0.2% | 91,200 |
| 2020/01/21 | 6,080 | 6,120 | 6,070 | 6,090 | ±0 | ±0% | 59,500 |
| 2020/01/20 | 6,090 | 6,110 | 6,050 | 6,090 | +20 | +0.3% | 80,900 |
| 2020/01/17 | 6,010 | 6,080 | 6,000 | 6,070 | +100 | +1.7% | 110,600 |
| 2020/01/16 | 5,990 | 5,990 | 5,910 | 5,970 | +30 | +0.5% | 82,700 |
| 2020/01/15 | 5,980 | 6,010 | 5,900 | 5,940 | -40 | -0.7% | 97,000 |
| 2020/01/14 | 5,980 | 6,010 | 5,940 | 5,980 | -60 | -1% | 88,600 |
| 2020/01/10 | 6,000 | 6,060 | 6,000 | 6,040 | +50 | +0.8% | 67,000 |
| 2020/01/09 | 5,950 | 6,020 | 5,920 | 5,990 | +120 | +2% | 73,600 |
| 2020/01/08 | 5,880 | 5,930 | 5,850 | 5,870 | -80 | -1.3% | 77,700 |
| 2020/01/07 | 5,890 | 5,960 | 5,880 | 5,950 | +30 | +0.5% | 95,000 |
| 2020/01/06 | 5,850 | 5,980 | 5,830 | 5,920 | -120 | -2% | 100,200 |
| 2019/12/30 | 5,970 | 6,060 | 5,950 | 6,040 | -30 | -0.5% | 59,900 |
| 2019/12/27 | 6,070 | 6,100 | 6,060 | 6,070 | -10 | -0.2% | 42,400 |
| 2019/12/26 | 6,010 | 6,080 | 6,000 | 6,080 | +70 | +1.2% | 53,500 |
| 2019/12/25 | 6,060 | 6,060 | 5,990 | 6,010 | -30 | -0.5% | 36,500 |
| 2019/12/24 | 6,070 | 6,080 | 6,000 | 6,040 | +10 | +0.2% | 49,600 |
| 2019/12/23 | 6,080 | 6,080 | 6,000 | 6,030 | -70 | -1.1% | 44,400 |
| 2019/12/20 | 6,160 | 6,160 | 6,050 | 6,100 | -50 | -0.8% | 80,000 |
| 2019/12/19 | 6,110 | 6,180 | 6,110 | 6,150 | +40 | +0.7% | 70,900 |
| 2019/12/18 | 6,100 | 6,110 | 6,050 | 6,110 | -10 | -0.2% | 97,900 |
| 2019/12/17 | 6,100 | 6,130 | 6,060 | 6,120 | +40 | +0.7% | 74,600 |
| 2019/12/16 | 6,040 | 6,150 | 6,030 | 6,080 | +50 | +0.8% | 100,800 |
| 2019/12/13 | 6,030 | 6,110 | 6,020 | 6,030 | +100 | +1.7% | 183,900 |
| 2019/12/12 | 5,960 | 5,980 | 5,910 | 5,930 | -40 | -0.7% | 72,900 |
| 2019/12/11 | 6,000 | 6,040 | 5,960 | 5,970 | -30 | -0.5% | 59,000 |
| 2019/12/10 | 6,010 | 6,020 | 5,960 | 6,000 | -10 | -0.2% | 87,700 |
| 2019/12/09 | 6,000 | 6,020 | 5,970 | 6,010 | +40 | +0.7% | 62,100 |
| 2019/12/06 | 5,940 | 5,990 | 5,930 | 5,970 | -10 | -0.2% | 56,100 |
| 2019/12/05 | 5,970 | 5,980 | 5,920 | 5,980 | +40 | +0.7% | 80,800 |
| 2019/12/04 | 5,890 | 5,970 | 5,880 | 5,940 | +30 | +0.5% | 75,700 |
| 2019/12/03 | 5,890 | 5,970 | 5,870 | 5,910 | -60 | -1% | 95,200 |
| 2019/12/02 | 5,930 | 5,980 | 5,910 | 5,970 | +80 | +1.4% | 78,800 |
| 2019/11/29 | 5,910 | 5,960 | 5,880 | 5,890 | +10 | +0.2% | 94,300 |
| 2019/11/28 | 5,890 | 5,900 | 5,830 | 5,880 | +20 | +0.3% | 72,300 |
| 2019/11/27 | 5,860 | 5,900 | 5,860 | 5,860 | +10 | +0.2% | 54,100 |
| 2019/11/26 | 5,900 | 5,900 | 5,820 | 5,850 | -10 | -0.2% | 153,100 |
| 2019/11/25 | 5,850 | 5,880 | 5,820 | 5,860 | +10 | +0.2% | 46,300 |
1301～
1350
件表示中 / 3713件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 381,000円 | -6.4% | -71.8% | 4.99% | 42.43倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 423,500円 | +3.6% | +6.1% | 2.83% | 14.27倍 | 0.84倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 321,500円 | +7.9% | -3.3% | 2.49% | 8.94倍 | 0.92倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 207,300円 | +3.1% | -6.5% | 2.32% | 9.62倍 | 1.02倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
